Robotic intracorporeal “Padua Ileal Bladder”: Surgical technique, perioperative, oncologic and functional outcomes

Giuseppe Simone1, Rocco Papalia2, Leonardo Misuraca1, Gabriele Tuderti1, Francesco Minisola1, Mariaconsiglia Ferriero1, Giulio Vallati3, Salvatore Guaglianone1, Michele Gallucci1
  • 1 Istituto Nazionale Tumori "Regina Elena", Unità di Urologia (Roma)
  • 2 Università Campus Biomedico, Dipartimento di Urologia (Roma)
  • 3 Istituto Nazionale Tumori "Regina Elena", Unità di Radiologia (Roma)


Robot-assisted radical cystectomy (RARC) with intracorporeal neobladder reconstruction is a challenging procedure. The aim of this video is to illustrate our technique for RARC and totally intracorporeal orthotopic “Padua Ileal Bladder”.
From August 2012 to February 2014, 45 patients underwent RARC, extended pelvic lymph node dissection and intracorporeal partly stapled neobladder at a single tertiary referral centre. Surgical steps are demonstrated in the accompanying video. Demographics, clinical and pathological data were collected. Perioperative, 2-yr oncologic and 2-yr functional outcomes were reported.
Intraoperative transfusion or conversion to open surgery was not necessary in any case and intracorporeal neobladder was successfully performed in all 45 patients. Median operative time was 305 minutes (IQR 282-345). Median estimated blood loss was 210 ml (IQR 50-250). Median hospital stay was 9 days (IQR 7–12). The overall incidence of perioperative, 30-d and 180-d complications were 44.4%, 57.8% and 77.8%, respectively, while severe complications occurred in 17.8%, 17.8% and 35.5%, respectively. Two-yr daytime and night-time continence rates were 73.3% and 55.5%, respectively. Two-yr disease free survival, cancer specific survival and overall survival rates were 72.5%, 82.3% and 82.4%, respectively.
Our experience supports the feasibility of totally intracorporeal neobladder following 
RARC. Operative times and perioperative complication rate are likely to be reduced with increasing experience.